Neuropsychopharmacology
- Incentive salience, not psychomotor sensitization or tolerance, drives escalation of cocaine self-administration in heterogeneous stock rats8 months ago
- Oxytocin neurons in the anterior and posterior paraventricular nucleus have distinct behavioral functions and electrophysiological profiles8 months ago
- Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia8 months ago
- Psychedelic therapeutics in psychiatric conditions8 months ago
- Choreographing time: toward therapy-aligned entactogens for complex PTSD8 months ago
- Psychotherapy for older adults with depression: a narrative review8 months ago
- Consciousness, subjectivity, and aging in western thought8 months ago
Journal of Psychopharmacology
- What are set and setting: Reducing vagueness to improve research and clinical practice1 year ago
- Centrally-acting opioid receptor antagonists as a treatment for antipsychotic-induced weight gain: A systematic review and meta-analysis of clinical trial data1 year ago
- Psychedelic-assisted psychotherapy: The need to monitor adverse events1 year ago
- Mapping acute alcohol effects on bodily sensations: A cross-dimensional interoceptive approach1 year ago
- Comparative efficacy, tolerability, and acceptability of aducanumab, lecanemab, and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis1 year ago
- Neurotransmitter modulation of human facial emotion recognition1 year ago
- Corrigendum: Is psychedelic use associated with cancer? Interrogating a half-century-old claim using contemporary population-level data1 year ago
European Neuropsychopharmacology
- Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study2 years ago
- Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”2 years ago
- A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder2 years ago
- Classical psychedelics in therapy: Essential psychotherapy or minimal support?2 years ago
- Differential effects of Xanomeline-trospium chloride on positive and negative symptoms in Schizophrenia: The role of dose2 years ago
- Lack of antidepressant-like effect of imipramine, fluoxetine and ketamine in the forced swim test in mice: How much standardization does a positive control require?2 years ago
- Disease continuum centered on Parkinson’s disease2 years ago